Capivasertib(Truqap)

Another NameTruqap、卡帕塞替尼、Capivasertib

IndicationsIt is indicated for patients with hormone receptor-positive (HR+)/human epidermal growth factor receptor 2-negative (HER2-) metastatic breast cancer who have disease progression after hormone therapy